Admelog Injection, Solution
Product Images NDC 0024-5926

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Admelog (NDC 0024-5926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Insulin 01)

Chemical structure diagram of insulin lispro showing the A-chain and B-chain amino acid sequences, including disulfide bonds linking the chains. Amino acids are represented as circles with labels and connected in a linear fashion to illustrate the peptide structure.*

FDA Label Image

Figure 1 (Insulin 02)

A line graph depicting the glucose infusion rate (GIR) in mg/min/kg over time in hours, showing the pharmacodynamic profile of ADMELOG (insulin lispro). The GIR peaks around 1 to 2 hours post-dose and gradually declines to near zero by 12 hours.*

FDA Label Image

Figure 2 (Insulin 03)

A line graph depicting mean plasma insulin lispro concentration (mU/L) over time (minutes). The curve shows a rapid rise in concentration peaking shortly after administration, followed by a gradual decline over several hours, illustrating the pharmacokinetic profile of insulin lispro.*

FDA Label Image

Image (Insulin 04)

Black and white line drawing showing hands handling a vial, with one hand holding the vial and the other hand removing the cap, illustrating preparation for an injection. This image is likely instructional for subcutaneous administration of insulin lispro solution.*

FDA Label Image

Image (Insulin 05)

A black and white instructional illustration showing two hands preparing an injection vial. One hand holds the vial while the other hand is peeling off a protective seal or cap from the top of the vial, demonstrating the first step in opening or preparing the medication for administration.*

FDA Label Image

Image (Insulin 06)

An instructional illustration showing a hand holding a syringe with an arrow indicating the direction to withdraw or inject liquid, likely demonstrating proper handling or use technique for an injection solution such as ADMELOG (insulin lispro) 100 U/mL.*

FDA Label Image

Image (Insulin 07)

An instructional illustration showing a hand holding a vial and a syringe. The syringe needle is being inserted into the vial, demonstrating the step of drawing medication from the vial prior to injection.*

FDA Label Image

Image (Insulin 08)

An instructional illustration showing a hand holding a syringe with the thumb pushing the plunger downward. The image likely demonstrates the proper technique for using the injection device, including the direction of pressure to administer the medication subcutaneously.*

FDA Label Image

Image (Insulin 09)

An instructional illustration showing a hand holding an insulin vial upside down and drawing insulin into a syringe, with an arrow indicating the motion of pulling the syringe plunger to fill it with insulin solution.*

FDA Label Image

Image (Insulin 10)

An instructional illustration showing preferred subcutaneous injection sites on a human body. Highlighted areas include the upper arms, stomach, thighs, and buttocks, indicated on both front and back views of the figure.*

FDA Label Image

Image (Insulin 11)

An instructional line drawing showing a hand holding a small vial or ampule while another hand uses a small object, possibly a needle or cap, to interact with it. The image appears to demonstrate a step in preparing an injection solution for use.*

FDA Label Image

Image (Insulin 12)

An illustration showing a hand holding a syringe with the other hand pulling back the plunger of the syringe to draw liquid into it. An arrow indicates the plunger being pulled back. No text or branding is visible in the image.*

FDA Label Image

Image (Insulin 13)

An illustration showing a human figure with injection sites highlighted in green on the upper arms, stomach, and thighs. Each injection area is clearly labeled, indicating common sites for subcutaneous injection.*

FDA Label Image

Image (Insulin 14)

An illustration showing the parts of the Admelog SoloStar insulin pen including the pen cap, cartridge holder, rubber seal, insulin scale, insulin name label, plunger, dose window, dose pointer, dose selector, and injection button. The diagram notes that the plunger is visible only after injecting a few doses.*

FDA Label Image

Image (Insulin 15)

The image shows an Admelog SoloStar prefilled pen labeled for insulin lispro injection at 100 units/mL strength. The pen contains 3 mL of solution for subcutaneous injection, intended for single patient use. The label includes dosage markings and the manufacturer is Sanofi-Aventis U.S. LLC.*

FDA Label Image

Image (Insulin 16)

An instructional illustration showing hands manipulating an ADMELOG insulin lispro 100 U/mL injection pen. The left part of the image shows a hand holding the pen with a visible dose window, while the right part shows a hand removing or attaching the pen cap, indicated by a blue arrow pointing to the right.*

FDA Label Image

Image (Insulin 17)

The image shows a 3 mL prefilled pen of Admelog SoloSTAR insulin lispro injection, 100 U/mL strength. The pen is designed for subcutaneous injection and is labeled for single patient use by Sanofi-Aventis U.S. LLC. A close-up of the dose window indicates selectable unit doses ranging from 20 to 260 units.*

FDA Label Image

Image (Insulin 18)

An instructional illustration showing hands preparing a syringe, focusing on the removal of a protective cap, likely related to the injection of ADMELOG (insulin lispro) 100 U/mL solution for subcutaneous use.*

FDA Label Image

Image (Insulin 19)

An instructional illustration showing hands removing the cap from a small vial or cartridge, demonstrating preparation steps for subcutaneous injection.*

FDA Label Image

Image (Insulin 20)

An instructional illustration showing a person holding an ADMELOG insulin lispro 100 U/mL injection pen. The image demonstrates twisting the pen cap to remove it, with arrows indicating the direction of rotation and pulling the cap off the pen.*

FDA Label Image

Image (Insulin 21)

Instructional diagram showing a hand holding a prefilled syringe labeled with a medication name, preparing to attach a needle cap. The second hand is shown removing the needle cap by pulling it straight off from its protective cover on a flat surface.*

FDA Label Image

Image (Insulin 22)

Illustration showing a hand removing the cap from a vial, positioned near an insulin pen with a visible dose window. The image demonstrates the initial steps for preparing an injection, likely for a subcutaneous insulin lispro solution such as ADMELOG 100 U/mL.*

FDA Label Image

Image (Insulin 23)

An instructional illustration showing hands adjusting a SoloStar insulin pen, focusing on setting the dose dial between values 1 and 2. The pen is labeled as an injection device for insulin solution, with a zoom inset highlighting the dose selector dial. The image demonstrates the action of selecting a specific dose by rotating the dial.*

FDA Label Image

Image (Insulin 24)

An instructional illustration showing proper handling of a syringe filled with a liquid medication. The image highlights the action of expelling air or testing the flow from the needle tip by pushing the plunger, indicated with an arrow and a close-up of liquid spray from the needle.*

FDA Label Image

Image (Insulin 25)

ADMELOG (insulin lispro) injection 100 units/mL in a 3 mL prefilled SoloStar pen for subcutaneous use. The pen shows dosage markings on the dose selector and a purple cap on the right end. Labeler is Sanofi-Aventis U.S. LLC.*

FDA Label Image

Image (Insulin 26)

An instructional illustration showing hands preparing an ADMELOG SoloStar injection pen by removing the protective cap. The image demonstrates how to hold the pen and the direction to pull the cap off in preparation for subcutaneous injection.*

FDA Label Image

Image (Insulin 27)

Illustration showing a close-up of a dosage dial on an insulin pen, displaying selectable dose increments. The dial numbers include 10, 20, and 30 units, indicating adjustable insulin dosing, typically used for subcutaneous injection.*

FDA Label Image

Image (Insulin 28)

FDA Label Image

Image (Insulin 29)

An instructional illustration showing a hand holding an ADMELOG insulin pen injection device. The syringe-like pen is positioned for subcutaneous injection with the needle pointing left. The illustration highlights how to hold and prepare the injection device for use.*

FDA Label Image

Image (Insulin 30)

An instructional diagram showing the proper technique for holding and twisting the dose knob of an ADMELOG insulin lispro injection pen. The image highlights using two fingers to turn the dose knob counterclockwise with a close-up of the correct hand position circled in blue, and a red-circled close-up indicating an incorrect grip position.*

FDA Label Image

Image (Insulin 31)

An instructional illustration showing a hand holding a syringe for subcutaneous injection. The syringe is positioned against skin, with a focus on pressing the plunger for 10 seconds to complete the injection. The diagram includes a blue clock icon indicating a 10-second duration.*

FDA Label Image

Image (Insulin 32)

An instructional illustration showing a hand holding an ADMELOG insulin lispro injection pen with a dose displayed on the dose selector. Another hand is attaching or removing a pen needle by screwing it onto the pen's tip cap, indicated by a blue arrow pointing right.*

FDA Label Image

Image (Insulin 33)

An instructional illustration showing hands holding an ADMELOG insulin lispro injection pen. The image depicts twisting the pen cap off and pressing the injection button, indicating steps for preparing or administering the subcutaneous injection using the pen device.*

FDA Label Image

Image (Insulin 34)

An instructional illustration showing two hands removing a protective seal and unscrewing a bottle cap, likely demonstrating how to open a vial or bottle. The image uses simple line art and a blue arrow to indicate the sequence of actions.*

FDA Label Image

Image (Insulin 35)

An instructional illustration showing the assembly of an ADMELOG insulin lispro injection pen with a 100 U/mL concentration. The image depicts hands attaching the pen cap onto the pen body, indicated by a blue arrow pointing to the left.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Packaging label for Admelog insulin lispro injection 100 units/mL (U-100) 10 mL vial by Sanofi-Aventis U.S. LLC. The label includes usage instructions for subcutaneous use and intravenous infusion only under medical supervision. Storage and handling instructions are also visible, along with a barcode and manufacturer details.*

FDA Label Image

Principal Display Panel (3 mL Pen Carton)

Packaging label for Admelog SoloStar insulin lispro injection 100 units/mL (U-100) in five 3 mL prefilled pens. The carton is labeled for single patient use only for subcutaneous injection. The labeler is Sanofi-Aventis U.S. LLC, and the carton includes storage instructions, usage warnings, a barcode, and the NDC 0024-5925-05.*

FDA Label Image

Principal Display Panel (3 mL Vial Carton)

The packaging label for Admelog insulin lispro injection, 100 units/mL (U-100) in a 3 mL vial, by Sanofi-Aventis U.S. LLC. The label includes dosage form and strength, instructions for subcutaneous use, storage conditions, warnings, and a barcode. The design features purple and white colors with the Sanofi logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.